Medical
Bristol-Myers Squibb is reportedly exiting its stake in a diabetes joint venture with AstraZeneca for $3 billion
Bristol-Myers Squibb is reportedly exiting its stake in a diabetes joint venture with AstraZeneca for $3 billion. Bristol-Myers shifted its focus from producing diabetes and hepatitis C treatment drugs to medicines harnessing the immune system to fight cancer.
Valeant to take over Solta Medical for $236 million
Solta Medical Inc. has put up the company for sale amid falling profits and pressure from activist investor Voce Capital Management LLC. California-based Valeant Pharmaceuticals International will buy Solta Medical for $236 million in cash.
GSK to hike stake in Indian subsidiary for $1.02 billion
British pharmaceutical corporation GlaxoSmithKline on Monday announced that it would buy up to 20.6 million shares in Indian subsidiary GlaxoSmithKline Pharmaceutical Ltd. for a total of $1.02 billion.
Ikaria receives final takeover bids from private equity firms
Pharmaceutical company Ikaria Inc. is seeking an exit reportedly worth $2 billion. Private equity firms American Securities LLC, GTCR LLC and Madison Dearborn Partners LLC have tendered their bids to acquire the American specialty drug manufacturer.